Aclaris Therapeutics, Inc.

ACRS

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001557746

SEC filings (opens in a new tab)

No open-market purchases or sales by Aclaris Therapeutics, Inc. insiders were filed in the last 90 days; 148 institutions reported holding it in 13F filings for Q2 2026, worth $630.0M in total; no superinvestor holds it.

Q2 2026 vs. Q1 2026

How the institutions holding Aclaris Therapeutics, Inc. changed between Q1 2026 and Q2 2026.

All holders in Q2 2026 All holders in Q1 2026

13F holders of ACRS: Q1 2026 compared with Q2 2026
Measure	Q1 2026	Of which not filed for Q2 2026	Q2 2026	Change
Holders	136	1	148	+13
Shares	109.2M	1.36K	119.1M	+9.93M (+9.1%)
Value	$409.4M	$5.09K	$630.0M	+$220.6M (+53.9%)

1 institution that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so the changes leave them out.

New holders (27)

Institutions that held Aclaris Therapeutics, Inc. at the end of Q2 2026 but not at the end of Q1 2026.

Institutions new to ACRS in Q2 2026
Institution	Shares	Value	% of portfolio
Silverarc Capital Management, LLC	1,946,482	$10.3M	1.15%
Jones Hill Capital LP	1,759,492	$9.31M	1.98%
OrbiMed Advisors LLC	421,500	$2.23M	0.04%
Polygon Management Ltd.	400,000	$2.12M	0.34%
Atom Investors LP	148,855	$787.4K	0.07%
Verition Fund Management LLC	98,000	$518.4K	0.00%
Voleon Capital Management LP	77,168	$408.2K	0.01%
Mangrove Partners	50,291	$266.0K	0.02%
Profund Advisors LLC	30,486	$161.3K	0.00%
State of Wyoming	27,439	$145.2K	0.01%
Rafferty Asset Management, LLC	21,997	$116.4K	0.00%
Walleye Capital LLC	19,576	$103.6K	0.00%
Empirical Financial Services, LLC d.b.a. Empirical Wealth Management	16,072	$85.0K	0.00%
Dynamic Technology Lab Private Ltd	13,521	$72.0K	0.02%
Xponance, Inc.	11,273	$59.6K	0.00%
Caitong International Asset Management Co., Ltd	5,677	$30.0K	0.00%
Quantbot Technologies LP	3,787	$20.0K	0.00%
SRS Capital Advisors, Inc.	786	$4.16K	0.00%
Advisor Group Holdings, Inc.	735	$3.89K	0.00%
Huntington National Bank	458	$2.42K	0.00%
Massmutual Trust Co FSB	391	$2.07K	0.00%
Optiver Holding B.V.	336	$1.78K	0.00%
Zions Bancorporation, National Association	156	$825	0.00%
National Bank of Canada	102	$540	0.00%
SJS Investment Consulting Inc.	102	$540	0.00%
Fortitude Family Office, LLC	56	$296	0.00%
Clearstead Advisors, LLC	6	$32	0.00%

Sold out (14)

Institutions that held Aclaris Therapeutics, Inc. at the end of Q1 2026 and filed for Q2 2026 without it.

Institutions that sold out of ACRS in Q2 2026
Institution	Shares, Q1 2026	Value, Q1 2026
Marshall Wace, LLP	712,984	$2.67M
Monashee Investment Management LLC	500,000	$1.88M
Mackenzie Financial Corp	213,405	$800.3K
Qube Research & Technologies Ltd	194,510	$729.4K
ADAR1 Capital Management, LLC	132,426	$496.6K
American Century Companies Inc	118,702	$445.1K
XTX Topco Ltd	97,774	$366.7K
EntryPoint Capital, LLC	33,007	$123.8K
Engineers Gate Manager LP	18,294	$68.6K
CIBC Asset Management Inc	17,428	$65.4K
ExodusPoint Capital Management, LP	16,895	$63.4K
MBM Wealth Consultants, LLC	3,198	$12.0K
Root Financial Partners, LLC	27	$101
MAI Capital Management	1	$4

Not filed for Q2 2026 yet (1)

Institutions that held Aclaris Therapeutics, Inc. at the end of Q1 2026 and haven't filed a 13F for Q2 2026. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding ACRS in Q1 2026 that haven't filed for Q2 2026
Institution	Shares, Q1 2026	Value, Q1 2026
CWM, LLC	1,358	$5.09K